OH Cleveland의 난소암 임상 시험
난소암 관련 연구 30개가 Cleveland 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
연구 대상자를 모집 중이신가요? 이 페이지 상단에 노출하세요 — 30일 동안 $99 →
The Vanguard Study: Testing a New Way to Screen for Cancer
피험자 모집 중건강한 지원자 환영
- Louis Stokes Cleveland VA Medical Center, Cleveland
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
피험자 모집 중2상
- Case Western Reserve University, Cleveland
- UHHS-Chagrin Highlands Medical Center, Beachwood · 10마일 거리
- UH Seidman Cancer Center at Lake Health Mentor Campus, Mentor · 22마일 거리
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
피험자 모집 중1상
- University Hospitals Cleveland Medical Center, Cleveland
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
피험자 모집 중1/2상
- The Cleveland Clinic Taussig Cancer Center, Cleveland
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
피험자 모집 중2상
- Cleveland Clinic - Oncology Department, Cleveland
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
피험자 모집 중2상
- University Hospitals Cleveland Medical Center /ID# 279601, Cleveland
Torvutatug Samrotecan Plus Bevacizumab as First-line Maintenance in Homologous Recombination Deficiency (HRD) Negative Advanced Epithelial Ovarian Cancer
피험자 모집 중3상
- Research Site, Cleveland
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
피험자 모집 중관찰 연구
- Cleveland Clinic, Cleveland
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
피험자 모집 중2상
- Metrohealth Medical Center - Cleveland /ID# 276664, Cleveland
- Cleveland Clinic - Cleveland /ID# 276133, Cleveland
- Cleveland Clinic - Cleveland /ID# 278273, Cleveland
- 외 1개
Study of AVZO-021 in Patients With Advanced Solid Tumors
피험자 모집 중1/2상
- Avenzo Therapeutics Recruiting Site, Cleveland
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
피험자 모집 중3상
- University Hospitals Cleveland Medical Center, Cleveland
- Fairview Hospital, Cleveland
- Cleveland Clinic, Cleveland
- 외 1개
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
피험자 모집 중1/2상
- UH Cleveland Medical Center, Cleveland
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
피험자 모집 중3상
- Cleveland Clinic Foundation, Cleveland
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
피험자 모집 중관찰 연구
- Cleveland Clinic, Cleveland
Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial
피험자 모집 중3상
- Cleveland Clinic, Cleveland
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
피험자 모집 중3상
- Cleveland Clinic, Cleveland
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
피험자 모집 중1상
- Cleveland Clinic Taussig Cancer Institute, Cleveland
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
피험자 모집 중
- Case Western Reserve University, Cleveland
- MetroHealth Medical Center, Cleveland
- Cleveland Clinic Cancer Center/Fairview Hospital, Cleveland
- 외 4개
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
피험자 모집 중3상
- Case Western Reserve University, Cleveland
- Cleveland Clinic Cancer Center/Fairview Hospital, Cleveland
- Cleveland Clinic Foundation, Cleveland
- 외 3개
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
피험자 모집 중1상
- University Hospital - Cleveland Medical Center, Cleveland
Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)
피험자 모집 중3상
- The Cleveland Clinic Foundation, Cleveland
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
피험자 모집 중1/2상
- UH Cleveland Medical Center, Cleveland
JAB-30355 in Patients With Advanced Solid Tumors Harboring TP53 Y220C Mutation
피험자 모집 중1/2상
- Research site, Cleveland
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
피험자 모집 중3상
- University Hospitals Cleveland Medical Center, Cleveland
- Cleveland Clinic, Cleveland
- UH Minoff Health Center at Chagrin Highlands, Orange · 12마일 거리
- 외 1개
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
피험자 모집 중관찰 연구
- University Hospitals Seidman Cancer Center, Cleveland
First in Human Study of TORL-1-23 in Participants With Advanced Cancer
피험자 모집 중1상
- Cleveland Clinic, Cleveland
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
피험자 모집 중관찰 연구건강한 지원자 환영
- Cleveland Clinic, Cleveland
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
피험자 모집 중관찰 연구
- Massive Bio SYNERGY-AI site, Mayfield Heights · 12마일 거리
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
피험자 모집 중1상
- Exelixis Clinical Site #7, Cleveland
Regorafenib Combined With Fulvestrant in Recurrent Low-Grade Serous Ovarian Cancer
피험자 모집 중2상
- University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland
다른 도시의 난소암 시험
- Houston, TX연구 89개
- New York City, NY연구 69개
- Boston, MA연구 61개
- Los Angeles, CA연구 50개
- Nashville, TN연구 49개
- Arlington, VA연구 46개
- Philadelphia, PA연구 44개
- Columbus, OH연구 39개
- St. Louis, MO연구 38개
- Chicago, IL연구 36개
- San Antonio, TX연구 31개
- Pittsburgh, PA연구 30개
Cleveland의 다른 연구
- 비소세포폐암연구 43개
- 암 (전체)연구 36개
- 유방암연구 35개
- 전립선암연구 34개
- 심부전연구 33개
- 전이성 암연구 30개
- 폐암연구 26개
- 대장직장암연구 24개
- 심혈관 질환연구 22개
- 자궁내막암연구 20개
- 급성 골수성 백혈병연구 20개
- 크론병연구 19개
ClinicalTrials.gov 출처, 2026. 10. 6. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.